R&D News | pharmaphorum

News

ABPI says UK clinical trials sector ‘improving’

There are glimmers of a recovery in the UK’s clinical research sector, with an uptick in the number of new studies being started, according to a new report.

News

Study finds trials of prescription DTx often lack ‘rigour’

A retrospective analysis of the clinical data supporting 20 FDA-approved prescription digital therapeutics has found that they often fail to apply rigorous standards of ev

News

Australian retail pharmacy enters clinical trials market

Australian retail pharmacy chain Chemist Warehouse has made a move into the clinical trials market with the help of virtual research organisation ObvioHealth.

News

Gilde’s new investment fund reaches €740m at close

Netherlands-based investment group Gilde Healthcare has finally closed its new Venture & Growth VI fund with committed funding of €740 million, well ahead of its origi

News

UK feels the chill of Pfizer’s cost-cutting wind

Pfizer has fleshed out some more of the details of its wide-ranging cost-cutting drive announced last month, revealing that around 500 jobs will go in the UK, including at

News

Autifony swings $770.5m deal with Jazz for CNS drugs

UK biotech Autifony has signed an exclusive licensing deal with Jazz Pharmaceuticals, giving the Ireland-headquartered drugmaker global rights to a pair of ion channel tar

ABPI says UK clinical trials sector ‘improving’

Study finds trials of prescription DTx often lack ‘rigour’

Australian retail pharmacy enters clinical trials market

Gilde’s new investment fund reaches €740m at close

UK feels the chill of Pfizer’s cost-cutting wind

Autifony swings $770.5m deal with Jazz for CNS drugs

On AI and computational support of biochemistry, with Alan R...

The AI imperative: Establishing the standard for modern clin...

News

Editor's Picks